articleTop 1% cited
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
Atherosclerosis · 1998 · Vol. 140(2) · pp. 199–270
David Wood✉(Imperial College London)Guy De BackerOle FærgemanIan D. GrahamGiuseppe Mancia(IRCCS Istituto Auxologico Italiano)Kalevi Pyörälà
Blood Pressure and Hypertension StudiesNutritional Studies and DietHealth Promotion and Cardiovascular PreventionTask forceMedicineCoronary heart diseaseCardiologyCoronary atherosclerosisInternal medicineClinical PracticePhysical therapyPolitical sciencePublic administration
MeSH terms
AdultAgedAntihypertensive AgentsHypolipidemic AgentsArteriosclerosisCoronary DiseaseDietEuropeFemaleHumansLife StyleLipidsMaleMiddle AgedPlatelet Aggregation Inhibitors
Citations
1,262
FWCI
55.24
field-weighted impact
References
497
Percentile
100%
vs. same field & year
Citations per year
Cited by
From Vulnerable Plaque to Vulnerable Patient
Circulation · 2003 · 2,669 citations
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)
The American Journal of Cardiology · 2003 · 1,392 citations
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
Circulation Research · 2016 · 1,066 citations
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
The Lancet · 2002 · 6,993 citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
European Heart Journal · 2016 · 3,169 citations
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
European Heart Journal · 2007 · 3,753 citations
European guidelines on cardiovascular disease prevention in clinical practice: Executive summary
Atherosclerosis · 2007 · 724 citations
References
PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events
Thrombosis and Haemostasis · 1997 · 388 citations
Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.
BMJ · 1988 · 2,217 citations
Beyond Cholesterol
New England Journal of Medicine · 1989 · 6,424 citations
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
JAMA · 1995 · 3,600 citations
Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease
Diabetes Care · 1991 · 4,536 citations
Ambulatory blood pressure normality
Journal of Hypertension · 1995 · 546 citations
Type A Behavior, Hostility, and Coronary Atherosclerosis*
Psychosomatic Medicine · 1980 · 596 citations
Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
The American Journal of Cardiology · 1992 · 889 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.